For adults with anemia who have HIV, the usual starting dose is 100 units per kilogram body weight, injected 3 times a week. For people with anemia due to chemotherapy, the starting dose is 150 units per kilogram of body weight, injected subcutaneously 3 times a week.

Eprex® is a man-made version of erythropoietin. In your body, your kidneys naturally produce erythropoietin when you have low oxygen levels. This substance helps your body make more red blood cells, which helps increase the amount of oxygen in your body. What do you need to know about me before I am able to receive Eprex®?

2025年1月7日 · Eprex regulates erythropoiesis by stimulating the differentiation and proliferation of erythroid precursors, stimulating the release of reticulocytes into the circulation, and …

For treatment of anaemia associated with renal insufficiency or chronic renal failure: ble. Where intravenous access is not readily available (patient not yet on dialysis and peritoneal dialysis patients) EPREX may be administered subcutaneously (See section 4.4 – Pure Red Cell Apl

Eprex (epoetin alfa) may be given either as an IV or SC injection (see 4.2 Recommended Dose and Dosage Adjustment, CRF PATIENTS). In order to ensure optimum response to Eprex, adequate iron stores should be assured and iron supplementation should be administered if necessary (see Product Monograph Part I: 7 WARNINGS AND PRECAUTIONS, Monitoring ...

EPREX injection is a clear, colourless solution in prefilled syringes of 1000 IU in 0.5 mL, 2000 IU in 0.5 mL, 3000 IU in 0.3 mL, 4000 IU in 0.4 mL, 5000 IU in 0.5 mL, 6000 IU in 0.6 mL, 8000 IU in 0.8 mL, 10000 IU in

2025年2月4日 · Eprex 40000 IU/ml solution for injection in pre-filled syringe - Summary of Product Characteristics (SmPC) by Janssen-Cilag Ltd (a Johnson & Johnson Company)

EPREX is used to treat anaemia in adults receiving chemotherapy for solid tumours, malignant lymphoma or multiple myeloma (bone marrow cancer) who may have a need for a blood transfusion. EPREX can reduce the need for a blood transfusion in these patients.

INICAL INFORMATION Indications EPREX® is indicated in patients with anemia symptoms associated with chronic renal function insufficiency (or hence require transfusion) and symptomatic anemia associated with chemotherapy [According to DoH Announcemen.

2025年1月24日 · EPREX vous est prescrit pour stimuler votre moelle osseuse afin de produire plus de globules rouges. · EPREX est utilisé dans le traitement de l’anémie chez les adultes recevant une chimiothérapie pour des tumeurs solides, un lymphome malin ou un myélome multiple (cancer de la moelle osseuse) et pouvant avoir besoin d’une transfusion de sang.